201 related articles for article (PubMed ID: 10648563)
1. Golgi alkalinization by the papillomavirus E5 oncoprotein.
Schapiro F; Sparkowski J; Adduci A; Suprynowicz F; Schlegel R; Grinstein S
J Cell Biol; 2000 Jan; 148(2):305-15. PubMed ID: 10648563
[TBL] [Abstract][Full Text] [Related]
2. E5 oncoprotein retained in the endoplasmic reticulum/cis Golgi still induces PDGF receptor autophosphorylation but does not transform cells.
Sparkowski J; Anders J; Schlegel R
EMBO J; 1995 Jul; 14(13):3055-63. PubMed ID: 7621820
[TBL] [Abstract][Full Text] [Related]
3. The transmembrane domain of the E5 oncoprotein contains functionally discrete helical faces.
Adduci AJ; Schlegel R
J Biol Chem; 1999 Apr; 274(15):10249-58. PubMed ID: 10187811
[TBL] [Abstract][Full Text] [Related]
4. E5 oncoprotein transmembrane mutants dissociate fibroblast transforming activity from 16-kilodalton protein binding and platelet-derived growth factor receptor binding and phosphorylation.
Sparkowski J; Mense M; Anders J; Schlegel R
J Virol; 1996 Apr; 70(4):2420-30. PubMed ID: 8642670
[TBL] [Abstract][Full Text] [Related]
5. A glutamine residue in the membrane-associating domain of the bovine papillomavirus type 1 E5 oncoprotein mediates its binding to a transmembrane component of the vacuolar H(+)-ATPase.
Goldstein DJ; Kulke R; Dimaio D; Schlegel R
J Virol; 1992 Jan; 66(1):405-13. PubMed ID: 1370089
[TBL] [Abstract][Full Text] [Related]
6. Vacuolar H(+)-ATPase mutants transform cells and define a binding site for the papillomavirus E5 oncoprotein.
Andresson T; Sparkowski J; Goldstein DJ; Schlegel R
J Biol Chem; 1995 Mar; 270(12):6830-7. PubMed ID: 7896830
[TBL] [Abstract][Full Text] [Related]
7. The human T-cell leukemia/lymphotropic virus type I p12I protein cooperates with the E5 oncoprotein of bovine papillomavirus in cell transformation and binds the 16-kilodalton subunit of the vacuolar H+ ATPase.
Franchini G; Mulloy JC; Koralnik IJ; Lo Monico A; Sparkowski JJ; Andresson T; Goldstein DJ; Schlegel R
J Virol; 1993 Dec; 67(12):7701-4. PubMed ID: 8230493
[TBL] [Abstract][Full Text] [Related]
8. A mutagenic analysis of the E5 protein of human papillomavirus type 16 reveals that E5 binding to the vacuolar H+-ATPase is not sufficient for biological activity, using mammalian and yeast expression systems.
Adam JL; Briggs MW; McCance DJ
Virology; 2000 Jul; 272(2):315-25. PubMed ID: 10873774
[TBL] [Abstract][Full Text] [Related]
9. Transformation-specific interaction of the bovine papillomavirus E5 oncoprotein with the platelet-derived growth factor receptor transmembrane domain and the epidermal growth factor receptor cytoplasmic domain.
Cohen BD; Goldstein DJ; Rutledge L; Vass WC; Lowy DR; Schlegel R; Schiller JT
J Virol; 1993 Sep; 67(9):5303-11. PubMed ID: 8394451
[TBL] [Abstract][Full Text] [Related]
10. Mutational analysis of the interaction between the bovine papillomavirus E5 transforming protein and the endogenous beta receptor for platelet-derived growth factor in mouse C127 cells.
Nilson LA; Gottlieb RL; Polack GW; DiMaio D
J Virol; 1995 Sep; 69(9):5869-74. PubMed ID: 7543592
[TBL] [Abstract][Full Text] [Related]
11. The human papillomavirus type 16 E5 protein alters vacuolar H(+)-ATPase function and stability in Saccharomyces cerevisiae.
Briggs MW; Adam JL; McCance DJ
Virology; 2001 Feb; 280(2):169-75. PubMed ID: 11162831
[TBL] [Abstract][Full Text] [Related]
12. The E5 protein of BPV-4 interacts with the heavy chain of MHC class I and irreversibly retains the MHC complex in the Golgi apparatus.
Marchetti B; Ashrafi GH; Dornan ES; Araibi EH; Ellis SA; Campo MS
Oncogene; 2006 Apr; 25(15):2254-63. PubMed ID: 16288210
[TBL] [Abstract][Full Text] [Related]
13. The HPV-16 E5 oncogene and bafilomycin A(1) influence cell motility.
Thomsen P; Rudenko O; Berezin V; Norrild B
Biochim Biophys Acta; 1999 Dec; 1452(3):285-95. PubMed ID: 10590317
[TBL] [Abstract][Full Text] [Related]
14. E5 oncoprotein mutants activate phosphoinositide 3-kinase independently of platelet-derived growth factor receptor activation.
Suprynowicz FA; Sparkowski J; Baege A; Schlegel R
J Biol Chem; 2000 Feb; 275(7):5111-9. PubMed ID: 10671555
[TBL] [Abstract][Full Text] [Related]
15. Identification of amino acids in the transmembrane and juxtamembrane domains of the platelet-derived growth factor receptor required for productive interaction with the bovine papillomavirus E5 protein.
Petti LM; Reddy V; Smith SO; DiMaio D
J Virol; 1997 Oct; 71(10):7318-27. PubMed ID: 9311809
[TBL] [Abstract][Full Text] [Related]
16. The v-sis protein retains biological activity as a type II membrane protein when anchored by various signal-anchor domains, including the hydrophobic domain of the bovine papilloma virus E5 oncoprotein.
Xu YF; Meyer AN; Webster MK; Lee BA; Donoghue DJ
J Cell Biol; 1993 Nov; 123(3):549-60. PubMed ID: 8227125
[TBL] [Abstract][Full Text] [Related]
17. c-Src activation by the E5 oncoprotein enables transformation independently of PDGF receptor activation.
Suprynowicz FA; Baege A; Sunitha I; Schlegel R
Oncogene; 2002 Mar; 21(11):1695-706. PubMed ID: 11896601
[TBL] [Abstract][Full Text] [Related]
18. Endoplasmic reticulum-localized human papillomavirus type 16 E5 protein alters endosomal pH but not trans-Golgi pH.
Disbrow GL; Hanover JA; Schlegel R
J Virol; 2005 May; 79(9):5839-46. PubMed ID: 15827198
[TBL] [Abstract][Full Text] [Related]
19. The BPV-1 E5 protein, the 16 kDa membrane pore-forming protein and the PDGF receptor exist in a complex that is dependent on hydrophobic transmembrane interactions.
Goldstein DJ; Andresson T; Sparkowski JJ; Schlegel R
EMBO J; 1992 Dec; 11(13):4851-9. PubMed ID: 1334459
[TBL] [Abstract][Full Text] [Related]
20. The E5 oncoprotein of bovine papillomavirus binds to a 16 kd cellular protein.
Goldstein DJ; Schlegel R
EMBO J; 1990 Jan; 9(1):137-45. PubMed ID: 1688529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
